E, E., MO, K., AM, B., AA, M., AA, E., E, H., . . . H, Z. (2026). Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: A randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05510-7
Chicago Style (17th ed.) CitationE, El-Khateeb, et al. "Repurposing Doxycycline as an Adjunct to Sitagliptin in Type 2 Diabetes Mellitus: A Randomized Controlled Study on Glycemic, Inflammatory, and Cardiometabolic Outcomes." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05510-7.
MLA (9th ed.) CitationE, El-Khateeb, et al. "Repurposing Doxycycline as an Adjunct to Sitagliptin in Type 2 Diabetes Mellitus: A Randomized Controlled Study on Glycemic, Inflammatory, and Cardiometabolic Outcomes." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05510-7.
